Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT1 | Q96EB6 | 1/20 | 0.50 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | NSD2 | O96028 | 1/20 | 0.48 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.48 |
| ▸ | HPGD | P15428 | 3/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.46 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.45 |
| ▸ | CHRNA7 | P36544 | 2/20 | 0.44 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.42 |
| ▸ | DHFR | P00374 | 1/20 | 0.42 |
| ▸ | MEN1 | O00255 | 1/20 | 0.42 |
| ▸ | BLM | P54132 | 1/20 | 0.42 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.41 |
| ▸ | TUBB | P07437 | 1/20 | 0.41 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL595125 | 0.89 | ALDH1A1 (0.46) | SIRT1MAPTKDM4ENSD2MAPK1 | |
| SCHEMBL22647159 | 0.82 | KDM4E (0.47) | SIRT1MAPTKDM4ENSD2MAPK1 | |
| SCHEMBL8720648 | 0.81 | SIRT1 (0.42) | SIRT1MAPTKDM4ENSD2MAPK1 | |
| SCHEMBL15509355 | 0.81 | SIRT1 (0.42) | SIRT1MAPTKDM4ENSD2MAPK1 | |
| SCHEMBL795029 | 0.81 | SIRT1 (0.54) | SIRT1MAPTKDM4ENSD2MAPK1 | |
| SCHEMBL487237 | 0.80 | SIRT1 (0.50) | SIRT1MAPTKDM4ENSD2MAPK1 | |
| SCHEMBL3900082 | 0.78 | SIRT1 (0.52) | SIRT1MAPTKDM4ENSD2MAPK1 | |
| SCHEMBL3897205 | 0.78 | SIRT1 (0.52) | SIRT1MAPTKDM4ENSD2MAPK1 | |
| SCHEMBL3897215 | 0.78 | SIRT1 (0.52) | SIRT1MAPTKDM4ENSD2MAPK1 | |
| SCHEMBL15509370 | 0.78 | STAT3 (0.44) | SIRT1MAPTKDM4ENSD2MAPK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 40 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3019510-B1 | USE OF IMMOBILIZED MOLYBDEN- UND TUNGSTEN-CONTAINING CATALYSTS IN OLEFIN CROSS METATHESIS | VERBIO VER BIOENERGIE AG (DE) | 2020-12-02 | — | — | EP | disclosed |
| EP-3662996-A2 | MOLYBDENUM AND TUNGSTEN COMPLEXES AS OLEFIN METATHESIS CATALYSTS AND REACTIONS USING THE CATALYSTS | Verbio Vereinigte BioEnergie AG (DE) | 2020-06-10 | — | — | EP | disclosed |
| US-10343153-B2 | Metathesis catalysts and reactions using the catalysts | XIMO AG (CH) | 2019-07-09 | — | — | US | disclosed |
| US-10230023-B2 | Color converter | BASF SE (DE) | 2019-03-12 | — | — | US | disclosed |
| EP-3019511-B1 | IMMOBILIZED METATHESIS TUNGSTEN CATALYSTS AND USE THEREOF IN OLEFIN METATHESIS | XIMO AG (CH) | 2019-01-02 | — | — | EP | disclosed |
| US-10071950-B2 | Use of immobilized molybdenum- and tungsten-containing catalysts in olefin cross metathesis | XIMO AG (CH) | 2018-09-11 | — | — | US | disclosed |
| US-9919299-B2 | Metathesis catalysts and reactions using the catalysts | XIMO AG (CH) | 2018-03-20 | — | — | US | disclosed |
| EP-2718395-B1 | Novel illumination device comprising a colour converter | BASF SE (DE) | 2018-02-28 | — | — | EP | disclosed |
| US-20160284947-A1 | NOVEL COLOR CONVERTER | BASF SE (DE) | 2016-09-29 | — | — | US | disclosed |
| US-9406848-B2 | Color converter | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| EP-2029573-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2009-03-04 | — | — | EP | disclosed |
| US-20080287678-A1 | Multiple Chromophores Based on Rylene | BASF AKTIENGESELLSCHAFT (DE) | 2008-11-20 | — | — | US | disclosed |
| US-20080245411-A1 | Fluorescent Solar Conversion Cells Based on Fluorescent Terylene Dyes | BASF SE | 2008-10-09 | — | — | US | disclosed |
| EP-1927141-A2 | FLUORESCENT SOLAR CONVERSION CELLS BASED ON FLUORESCENT TERYLENE DYES | BASF SE (DE) | 2008-06-04 | — | — | EP | disclosed |
| EP-1917311-A2 | MULTIPLE CHROMOPHORES | BASF SE (DE) | 2008-05-07 | — | — | EP | disclosed |
| EP-1904497-A1 | SUBSTITUTED RYLENE DERIVATIVES | BASF SE (DE) | 2008-04-02 | — | — | EP | disclosed |
| WO-2007138051-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007031446-A2 | FLUORESCENT SOLAR CONVERSION CELLS BASED ON FLUORESCENT TERYLENE DYES | BASF SE (DE) | 2007-03-22 | — | — | WO | disclosed |
| WO-2007014902-A2 | MULTIPLE CHROMOPHORES BASED ON RYLENE | BASF SE (DE) | 2007-02-08 | — | — | WO | disclosed |
| WO-2007006717-A1 | SUBSTITUTED RYLENE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10343153-B2 | Metathesis catalysts and reactions using the catalysts | MSMO1, SQLE, MOGAT2 | SIRT1 3164/4885MAPT 3427/4885KDM4E 3415/4885 |
| US-20080287678-A1 | Multiple Chromophores Based on Rylene | TDO2, PPOX, NPY1R | SIRT1 910/4885MAPT 4684/4885KDM4E 706/4885 |
| US-10071950-B2 | Use of immobilized molybdenum- and tungsten-containing catalysts in olefin cross metathesis | DUOX1, DUOX2, MSN | SIRT1 2939/4885MAPT 3914/4885KDM4E 3943/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.